Myo-Inositol vs D-Chiro: Which Ratio Do You Need?
Research supports a 40:1 ratio of myo-inositol to D-chiro-inositol (DCI) for hormonal balance support. Taking DCI alone at high doses may be counterproductive.
Updated 2026 · Reviewed by Dr. Brennan Commerford, D.C.
Our Recommendation
Myo-Inositol (in 40:1 ratio with DCI)
The 40:1 myo-inositol:DCI ratio mirrors the physiological ratio found in human follicular fluid, with the strongest evidence base for hormonal balance support.
Myo-Inositol + DCI (40:1) vs D-Chiro-Inositol (DCI) Alone
Myo-Inositol + DCI (40:1)
Pros
- +Mirrors the 40:1 ratio found in human follicular fluid
- +Most studied combination for hormonal balance support in women
- +Myo-inositol is the primary active form; DCI acts as co-factor
Cons
- -Requires finding a product that delivers both in the correct ratio
- -Higher dose volume (typically 2–4 g myo-inositol + 50–100 mg DCI)
Best For
Women seeking hormonal balance support and ovarian function support through the research-validated ratio.
Physiological ratio — aligned with human follicular fluid composition
D-Chiro-Inositol (DCI) Alone
Pros
- +Active co-factor in insulin signaling pathways
- +May support insulin sensitivity as a standalone agent
- +Lower dose volume than myo-inositol
Cons
- -High-dose DCI alone may paradoxically impair follicular function
- -Does not supply myo-inositol, which is the dominant active form
- -Less research support for hormonal balance vs the combined 40:1 approach
Best For
Those specifically interested in DCI's role in insulin signaling, used at low doses.
Secondary inositol isomer — effective at low doses in ratio with myo-inositol
Frequently Asked Questions
- Why is the 40:1 ratio important?
- Human follicular fluid naturally contains myo-inositol and D-chiro-inositol at approximately a 40:1 ratio — a physiological finding replicated across multiple ovarian physiology characterization studies. Supplementing to restore this ratio is the approach supported by the strongest published evidence for hormonal balance.
- What dose of myo-inositol is used in studies?
- Most published studies use 2–4 g/day of myo-inositol, often combined with 50–100 mg of D-chiro-inositol to achieve the 40:1 ratio. Doses are typically divided into two administrations.
- Can too much DCI be harmful?
- Supplementation protocols using DCI alone at high doses — without myo-inositol co-administration — have raised concerns in the inositol literature about follicular function. This is why standalone high-dose DCI is not supported for hormonal balance goals — the 40:1 combined approach is the evidence-supported method.
Ready to formulate with Myo-Inositol (in 40:1 ratio with DCI)?
Build your personalized formula with research-backed dosing.
Start My FormulaRelated Resources
DCI Alone Can Backfire — The 40:1 Ratio Your Follicular Fluid Expects
The 40:1 ratio mirrors the physiological myo-inositol to D-chiro-inositol concentration found in human follicular fluid. Published supplementation trials using this ratio report the strongest hormonal balance outcomes. DCI alone can paradoxically worsen results — our guide explains why.
See the Ratio ResearchFormulaForge formulates and sells supplements containing the ingredients discussed on this page. Our formulary recommendations are based on peer-reviewed bioavailability research. All cited studies are independently verifiable.